Recent Post
Related Posts
IGC Pharma Expands AI Platform with Advanced Diagnostic Model for Alzheimer’s and Dementia Detection
POTOMAC, MARYLAND – March 4, 2025 – IGC Pharma, Inc. (“IGC†or the “Companyâ€) (NYSE American: IGC) today announced an advancement in its Artificial Intelligence (“AIâ€) platform with the development
January 28, 2025 – The “Company” is proud to announce its selection as one of the top 15 finalists in the PREPARE Challenge – Phase 2: Model Arena (Acoustic Track),
October 01, 2024Â The “Company” is proud to announce that it won 2 awards in the PREPARE Challenge (Pioneering Research for Early Prediction of Alzheimer’s and Related Dementias EUREKA Challenge), with